Spherix's Annual Meeting of Shareholders to be held on November 17

Sep 24 2009

Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Annual Meeting of Shareholders will be held on November 17, 2009, at 9:00 a.m. Eastern time, at the Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, Maryland 20817.

The items of business are:

1. Election of seven Directors.
2. Ratification of the appointment of the independent accountants.
3. Proposal to authorize a reverse stock split of the Company's issued and outstanding common stock at a ratio to be designated by the Board of Directors within a range of 1:5 to 1:20.
4. Transaction of other business that may properly come before the meeting.

In addition, the Company has fixed the close of business on September 18, 2009, as the Record Date for determination of shareholders entitled to notice of and to vote at the Annual Meeting and any adjournment thereof. Only shareholders of record on the date so fixed are entitled to vote. Proxy materials will be mailed to these shareholders on or about September 30, 2009.